Skip to main content

Market Overview

70 Biggest Movers From Yesterday

Share:
70 Biggest Movers From Yesterday

Gainers

  • Nemaura Medical Inc. (NASDAQ: NMRD) shares surged 135.3% to close at $11.06 on Wednesday after the company receipt of a purchase order for 5,000 sugarBEAT transmitters and 200,000 sugarBEAT sensors from its U.K. licensee, DB Ethitronix Ltd.
  • Regional Health Properties, Inc. (NYSE: RHE) jumped 96.3% to close at $19.49.
  • The Honest Company, Inc. (NASDAQ: HNST) shares climbed 43.8% to settle at $23.00 after the company priced its IPO at $16 per share.
  • Chiasma, Inc. (NASDAQ: CHMA) rose 40.1% to settle at $3.98 after Amryt Pharma agreed to acquire the company in an all-stock combination.
  • Big 5 Sporting Goods Corporation (NASDAQ: BGFV) jumped 31.2% to settle at $25.01 after the company reported better-than-expected Q1 results and also issued strong Q2 EPS guidance.
  • American Shared Hospital Services (NYSE: AMS) jumped 30.5% to close at $3.55 after dropping over 27% on Tuesday.
  • SunLink Health Systems, Inc. (NYSE: SSY) gained 29.8% to close at $3.70.
  • Ever-Glory International Group, Inc. (NYSE: EVK) rose 29.2% to settle at $3.05.
  • KBS Fashion Group Limited (NASDAQ: KBSF) gained 25.9% to close at $3.55.
  • Hayward Holdings, Inc. (NASDAQ: HAYW) gained 24.3% to settle at $24.11 after the company reported better-than-expected Q1 sales.
  • InnSuites Hospitality Trust (NYSE: IHT) rose 24.3% to close at $2.56.
  • Alfi, Inc. (NASDAQ: ALF) gained 23.5% to settle at $3.58. Alfi recently reported pricing of $15.5 million initial public offering and Nasdaq listing.
  • Altisource Portfolio Solutions S.A. (NASDAQ: ASPS) surged 23.3% to close at $7.21.
  • Athenex, Inc. (NASDAQ: ATNX) shares jumped 22.6% to settle at $4.55 after the company reported its acquired Kuur Therapeutics Inc, a portfolio company of IP Group plc, for $70 million upfront.
  • Superior Industries International, Inc. (NYSE: SUP) rose 22.1% to close at $6.26 following Q1 results.
  • Five Star Bancorp (NASDAQ: FSBC) gained 21.3% to settle at $24.25 after pricing its IPO at $20 a share.
  • Fresh Del Monte Produce Inc. (NYSE: FDP) jumped 20% to close at $34.63 following strong quarterly earnings.
  • Interlink Electronics, Inc. (NASDAQ: LINK) gained 19.8% to close at $13.78.
  • Aziyo Biologics, Inc. (NASDAQ: AZYO) surged 18.4% to close at $11.26 after the company reported better-than-expected Q1 results.
  • KLX Energy Services Holdings, Inc. (NASDAQ: KLXE) gained 18.4% to settle at $10.56.
  • Oceaneering International, Inc. (NYSE: OII) climbed 18.2% to settle at $13.91. B of A Securities upgraded Oceaneering International from Neutral to Buy and raised the price target from $12.5 to $15.
  • DAVIDsTEA Inc. (NASDAQ: DTEA) shares surged 18% to settle at $3.80 after the company announced it will seek court authorization for Companies' Creditors Arrangement Act.
  • Rocky Brands, Inc. (NASDAQ: RCKY) climbed 16.2% to close at $62.50 after reporting a rise in quarterly earnings.
  • KAR Auction Services, Inc. (NYSE: KAR) shares surged 16% to settle at $16.83 following upbeat quarterly results.
  • iBio, Inc. (NYSE: IBIO) gained 14.7% to close at $1.48 after the company announced it successfully resolved its lawsuit with Fraunhofer USA.
  • Universal Security Instruments, Inc. (NYSE: UUU) gained 14.3% to close at $6.46 on above-average volume.
  • Peabody Energy Corporation (NYSE: BTU) surged 14.2% to settle at $4.74 amid strength in coal names.
  • MRC Global Inc. (NYSE: MRC) jumped 14.1% to settle at $11.01.
  • Medifast, Inc. (NYSE: MED) rose 12.1% to close at $252.28 after the company reported better-than-expected Q1 results and issued strong FY21 EPS and sales guidance.
  • Belden Inc. (NYSE: BDC) surged 11.9% to close at $48.22 after the company reported better-than-expected Q1 results and raised FY21 sales guidance.
  • XP Inc. (NASDAQ: XP) surged 11.3% to close at $42.77 after the company reported Q1 net income and total gross sales results up from last year.
  • Caesarstone Ltd. (NASDAQ: CSTE) rose 10.6% to close at $15.95 following strong quarterly results.
  • Nabors Industries Ltd. (NYSE: NBR) rose 10.2% to close at $89.30.
  • Express, Inc. (NYSE: EXPR) gained 10.1% to settle at $3.49.
  • Navios Maritime Holdings Inc. (NYSE: NM) rose 8.1% to close at $9.80.
  • Caesars Entertainment, Inc. (NASDAQ: CZR) gained 7.8% to close at $102.98 after the company reported Q1 earnings results.
  • NOW Inc. (NYSE: DNOW) gained 7.2% to settle at $10.91 after the company reported better-than-expected Q1 results.
  • Ault Global Holdings, Inc. (NYSE: DPW) rose 6.4% to close at $2.82 after the company reported it sees preliminary Q1 sales of $13 million, up 132% year over year.
  • Clovis Oncology, Inc. (NASDAQ: CLVS) gained 6.4% to close at $5.86 after the company posted a narrower-than-expected quarterly loss.

 

 

Check out these big penny stock gainers and losers

Losers

  • Cocrystal Pharma, Inc. (NASDAQ: COCP) shares dipped 31.3% to close at $1.47 on Wednesday after the company announced a $40 million bought deal offering of common stock.
  • Intrusion Inc. (NASDAQ: INTZ) fell 28.8% to close at $10.25 after the company reported worse-than-expected Q1 results. B. Riley FBR downgraded Intrusion from Buy to Neutral and lowered the price target from $30 to $13.5.
  • Sequential Brands Group, Inc. (NASDAQ: SQBG) fell 27.1% to close at $12.40, potentially on continued weakness after the stock fell on Tuesday following the resignation of the company's chairman.
  • Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) dipped 23.4% to settle at $0.8202 after surging 40% on Tuesday.
  • Rayonier Advanced Materials Inc. (NASDAQ: RYAM) dropped 23.3% to close at $6.99 after reporting a loss for its first quarter.
  • BioLineRx Ltd. (NASDAQ: BLRX) fell 23.3% to close at $3.75. BioLineRx shares climbed 53% on Tuesday after the company announced positive top-line results from the GENESIS Phase 3 trial evaluating its lead clinical candidate, Motixafortide, in combination with granulocyte colony stimulating factor, the standard-of-care, for hematopoietic stem-cell mobilization for autologous bone marrow transplantation in multiple myeloma patients.
  • Brooklyn ImmunoTherapeutics, Inc. (NYSE: BTX) fell 21.9% to settle at $43.09. Last week, Brooklyn ImmunoTherapeutics filed a Form 8-K showing that it entered into a purchase agreement with Lincoln Park Capital on Apr. 26 in which the company can sell up to $20 million of common shares to the Chicago-based investment group and asset management firm. Additionally, Nicholas J Singer disclosed that he took a 9%-plus stake in the company in a 13G filing on Friday.
  • Esperion Therapeutics, Inc. (NASDAQ: ESPR) shares dipped 21.8% to close at $20.01 after the company reported worse-than-expected Q1 results. Stifel downgraded Esperion Therapeutics from Buy to Hold and lowered the price target from $37 to $20.
  • Systemax Inc. (NYSE: SYX) dropped 21.8% to close at $33.38 after the company posted downbeat quarterly results.
  • Team, Inc. (NYSE: TISI) fell 18.5% to settle at $8.57 after the company late Tuesday reported worse-than-expected Q1 results.
  • Mercury Systems, Inc. (NASDAQ: MRCY) fell 17.8% to close at $57.69 after reporting Q3 results.
  • PDS Biotechnology Corporation (NASDAQ: PDSB) dipped 17.6% to close at $4.96.
  • Cardlytics, Inc. (NASDAQ: CDLX) fell 17% to close at $106.34 after reporting a Q1 loss.
  • Bottomline Technologies (de), Inc. (NASDAQ: EPAY) dipped 16.8% to close at $38.55 after the company reported worse-than-expected Q3 sales results. Craig-Hallum downgraded Bottomline Technologies from Buy to Hold.
  • Vaxart, Inc. (NASDAQ: VXRT) fell 15.8% to close at $7.38, potentially amid profit taking after the stock gained on Tuesday following oral COVID-19 data.
  • FedNat Holding Company (NASDAQ: FNHC) fell 15.4% to close at $4.35 following weak quarterly results.
  • IM Cannabis Corp. (NASDAQ: IMCC) fell 15.4% to close at $5.43 after the company reported pricing of proposed public offering of securities.
  • MoSys, Inc. (NASDAQ: MOSY) dipped 15.3% to settle at $3.81.
  • Intellicheck, Inc. (NYSE: IDN) fell 15.2% to close at $8.14 after the company reported worse-than-expected Q1 EPS and sales results.
  • Kimball International, Inc. (NASDAQ: KBAL) dropped 15% to close at $12.37 following weak quarterly results.
  • Silk Road Medical, Inc (NASDAQ: SILK) fell 14.8% to settle at $52.33 after the company reported Q1 earnings results.
  • Alector, Inc. (NASDAQ: ALEC) fell 14.7% to close at $15.71.
  • Peloton Interactive, Inc. (NASDAQ: PTON) dipped 14.6% to close at $82.62.
  • Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) fell 14.5% to settle at $37.02 after the company reported Q1 earnings results. Following earnings, HC Wainwright & Co lowered its price target on the stock from $80 to $75.
  • Astec Industries, Inc. (NASDAQ: ASTE) dropped 14.4% to close at $65.95 following downbeat quarterly results.
  • Myriad Genetics, Inc. (NASDAQ: MYGN) fell 13% to close at $27.51.
  • Sana Biotechnology, Inc. (NASDAQ: SANA) dropped 13% to settle at $16.67.
  • CyberArk Software Ltd. (NASDAQ: CYBR) dipped 11.7% to settle at $119.17 after the company issued mixed Q2 guidance.
  • SemiLEDs Corporation (NASDAQ: LEDS) fell 7.4% to close at $5.50 after jumping 58% on Tuesday.
  • Lumber Liquidators Holdings, Inc. (NYSE: LL) fell 6.7% to close at $23.09 following downbeat quarterly sales.
  • Dolby Laboratories, Inc. (NYSE: DLB) fell 6.3% to close at $96.98 after the company issued Q3 EPS guidance below analyst estimates. The company also said Lewis Chew, Executive Vice President and Chief Financial Officer has decided to retire later this year.
 

Related Articles (ADMP + ALEC)

View Comments and Join the Discussion!

Posted-In: Movers From YesterdayNews Penny Stocks Small Cap Pre-Market Outlook Markets Movers Trading Ideas

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com